Antibiotic Resistance Profiles in Septicaemia: A Retrospective Study of Gram-Positive and Gram-Negative
Article Sidebar
Views | PDF/EPUB Downloads:
107
/ 57
/ 38
Main Article Content
Abstract
Septicaemia, a severe systemic inflammatory response caused by bloodstream bacterial infection, is frequently associated with gram-negative bacteria and high morbidity and mortality. Antibiotic resistance complicates treatment, necessitating research on resistance patterns to guide empirical therapy. This study aimed to investigate the aetiology of septicaemia and its associated antibiotic resistance patterns in patients at PKU Muhammadiyah Surakarta Hospital, Indonesia. A retrospective analysis of patients treated for bacterial infections (January–December 2022) was conducted using blood culture and antibiotic therapy data. Bacterial susceptibility was assessed via the BacT/Alert Blood Culture System, and statistical analysis was performed using SPSS version 25. Among 51 patients, 51% were male, and 84.3% were aged >65 years. Comorbidities included diabetes mellitus (15.7%) and hypertension (9.8%), with a mortality rate of 58.8%. Gram-positive bacteria predominated (66.7%), primarily Staphylococcus aureus (49.0%), while gram-negative bacteria accounted for 33.3%, predominantly Escherichia coli (13.7%). S. aureus showed resistance to 17 antibiotics but remained susceptible to imipenem and vancomycin; E. coli exhibited significant multidrug resistance. These findings highlight the prevalence of Gram-positive pathogens and substantial Gram-negative resistance in septicaemia, underscoring the need for targeted antibiotic strategies to improve outcomes and combat resistance.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
1.Yang M, Wang Y, Zhang Y, Li Y, Li Q, Tan J. Role of interleukin-33 in Staphylococcus epidermidis-induced septicemia. Front. Immunol. 2020;11:534099. Doi: 10.3389/fimmu.2020.534099
2.Tang A, Shi Y, Dong Q, Wang S, Ge Y, Wang C, Gong Z, Zhang W, Chen W. Prognostic differences in sepsis caused by gram-negative bacteria and gram-positive bacteria: a systematic review and meta-analysis. Crit. Care. 2023;27(1):467. Doi: 10.1186/s13054-023-04750-w.
3.Bajaj A, Mishra B, Loomba PS, Thakur A, Sharma A, Rathod PG, Das M, Bhasin A. Prevalence of Gram-negative Septicemia in a Tertiary Care Center. J. Med. Sci. Health. 2019;05(01):36–41. Doi: 10.46347/jmsh.2019.v05i01.007
4.Osei Sekyere J, Reta MA. Genomic and Resistance Epidemiology of Gram-Negative Bacteria in Africa: a Systematic Review and Phylogenomic Analyses from a One Health Perspective. mSystems. 2020;5(6):e00897–20. Doi: 10.1128/mSystems.00897-20
5.Ramachandran G. Gram-positive and gram-negative bacterial toxins in sepsis: a brief review. Virulence. 2014;5(1):213–218. Doi: 10.4161/viru.27024
6.Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, Ikuta KS, Kissoon N, Finfer S, Fleischmann-Struzek C, Machado FR, Reinhart KK, Rowan K, Seymour CW, Watson RS, West TE, Marinho F, Hay SI, Lozano R, Lopez AD, Angus DC, Murray CJL, Naghavi M. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. The Lancet. 2020;395(10219):200–211. Doi: 10.1016/S0140-6736(19)32989-7
7.Priyatiningsih DR, Latief A, Pudjiadi A. Characteristics of sepsis in the pediatric intensive care unit of Dr. Cipto Mangunkusumo National Hospital. Universitas Indonesia; 2016.
8.Sanderson M, Chikhani M, Blyth E, Wood S, Moppett IK, McKeever T, Simmonds MJR. Predicting 30-day mortality in patients with sepsis: An exploratory analysis of process of care and patient characteristics. J. Intensive Care Soc. 2018;19(4):299–304. Doi: 10.1177/1751143718758975
9.Starr ME, Saito H. Sepsis in old age: review of human and animal studies. Aging Dis. 2014;5(2):126. Doi: 10.14336/AD.2014.0500126.
10.Hambali W, Chen LK, Widodo D, Dewiasty E, Pohan HT, Suhendro S. The Role of Lactate Clearance in Severe Septic Patients Survival. JDPI. 3(1):7. Doi: 10.7454/jpdi.v3i1.114
11.Khan MR, Azam S, Ahmad S, Ali Q, Liaqat Z, Rehman N, Khan I, Alharbi M, Alshammari A. Molecular Characterization and epidemiology of antibiotic resistance genes of β-lactamase producing bacterial pathogens causing septicemia from tertiary care hospitals. Antibiotics. 2023;12(3):617. Doi: 10.3390/antibiotics12030617
12.Sutrisna E. Rational Use of Antibiotic. Universitas Muhammadiyah Surakarta; 2012.
13.Bestari MP, Karuniawati H. Evaluation of Rationality and Effectiveness of Antibiotic Use in Hospitalized Pediatric Pneumonia Patients in Center Hospital, Central Java, Indonesia Mahardika. Pharmacon. 2019;14(2):62–71. Doi: 10.23917/pharmacon.v14i2.6524
14.Suminar FD, Sutrisna EM. Evaluation of the Rationality of Antibiotic Use in Children's Pneumonia at Dr. Moewardi Regional Hospital and Klaten Islamic Hospital. Surakarta: Universitas Muhammadiyah Surakarta; 2020.
15.Dewi LM, Nafi’ah MQ. Effectiveness of 96% Ethanol Extract of Clove Leaves (Syzygium aromaticum (L.) Merr & Perry) as an Antibacterial Agent Against Staphylococcus epidermidis and Providencia stuartii. magnamed. 2022;9(2):139. Doi: 10.26714/magnamed.9.2.2022.139-146
16.Ezeibe EN, Onuigbo EB, Ugwu CN, Berebon DP, Gugu TH, Nwagwu CS, Attama AA. Fluoroquinolones resistance and plasmid profile patterns of typhoidal Salmonella serovars isolated from human faecal samples in tertiary hospitals in South-East, Nigeria. Trop J. Nat Prod Res. 2022;6(1):138–43. Doi:10.26538/tjnpr/v6i1.22
17.Sovia E, Ratwita W, Fitriyanto IA, Nurlaela L. Education on the wise and safe use of antibiotics. JKPKM. 2023;6(3):1–14.
18.Anggraini D, Yovi I, Yepri R, Christianto E, Syarputri EZ. Bacterial and Antibiogram Patterns for Diabetic Ulcers in X Hospital Riau 2015-2018. Biomedika. 2020;12(1):27–35. Doi: 10.23917/biomedika.v12i1.9316
19.Gebremariam NM, Bitew A, Tsige E, Woldesenbet D, Tola MA. A High Level of Antimicrobial Resistance in Gram-Positive Cocci Isolates from Different Clinical Samples Among Patients Referred to Arsho Advanced Medical Laboratory, Addis Ababa, Ethiopia. Infect Drug Resist. 2022;15:4203–4212. doi: 10.2147/IDR.S372930
20.CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 26th Ed. C. Wayne, PA: Clinical and Laboratory Standards Institute; 2016.
21.Pradipta IS, Sodik DC, Lestari K, Parwati I, Halimah E, Diantini A, Abdulah R. Antibiotic resistance in sepsis patients: evaluation and recommendation of antibiotic use. N Am J. Med Sci. 2013;5(6):344–352. Doi: 10.4103/1947-2714.114165
22.Jannah SN, Arfijanto MV, Rusli M, Widodo ADW. Sepsis: Antibiotic Resistances of Gram-Positive and Gram-Negative Bacterial in a Tertiary Care Hospital. JUXTA. 2021;12(1):29. Doi: 10.20473/juxta.V12I12021.29-37
23.Deva A, Namitha BN. Aerobic Bacterial Profile of Sepsis and Its Antibiotic Susceptibility Pattern Among Patients in a Rural Tertiary Care Center. Cureus. 2023;15(12):e49942. Doi: 10.7759/cureus.49942
24.Syaputra A, Wijaya DW, Hanafie A. Patterns of Antibiotic Use in The One Hour Bundle Treatment of Sepsis. J. Soc Med. 2022;1(3):108–114. Doi: 10.47353/jsocmed.v1i3.17
25.Lakbar I, Einav S, Lalevée N, Martin-Loeches I, Pastene B, Leone M. Interactions between Gender and Sepsis-Implications for the Future. Microorganisms. 2023;11(3): 746. Doi: 10.3390/microorganisms11030746
26.Wardi G, Tainter CR, Ramnath VR, Brennan JJ, Tolia V, Castillo EM, Hsia RY, Malhotra A, Schmidt U, Meier A. Age-related incidence and outcomes of sepsis in California, 2008-2015. J. Crit. Care. 202;62:212–217. Doi: 10.1016/j.jcrc.2020.12.015.
27.Ibarz M, Haas LEM, Ceccato A, Artigas A. The critically ill older patient with sepsis: a narrative review. Ann Intensive Care . 2024;14(1):6. Doi: 10.1186/s13613-023-01233-7
28.Novosad SA, Sapiano MRP, Grigg C, Lake J, Robyn M, Dumyati G, Felsen A, Blog D, Dufort E, Zansky E, Wiedeman K, Avery L, Dantes RB, Jernigan JA, Magill SS, Fiore A, Epstein L. Vital Signs: Epidemiology of Sepsis: Prevalence of Health Care Factors and Opportunities for Prevention. MMWR Morb Mortal Wkly Rep. 2016;65(33):864–869. Doi: 10.15585/mmwr.mm6533e1.
29.Belew H, Tamir W, Dilnessa T, Mengist A. Phenotypic Bacterial Isolates, Antimicrobial Susceptibility pattern and Associated factors among Septicemia Suspected Patients at a hospital, in
30.Northwest Ethiopia: Prospective cross-sectional study. Ann Clin Microbiol. Antimicrob. 2023;22(1):47. doi: 10.1186/s12941-023-00599-7.
31.Ahmed NH, Baruah FK, Grover RK. Staphylococcus hominis subsp. novobiosepticus, an emerging multidrug-resistant bacterium, as a causative agent of septicaemia in cancer patients. Indian J. Med Res. 2017;146(3):420–425. Doi: 10.4103/ijmr.IJMR_1362_15.
32.Itani R, Khojah HMJ, Karout S, Rahme D, Hammoud L, Awad R, Abu-Farha R, Mukattash TL, Raychouni H, El-Lakany A. Acinetobacter baumannii: assessing susceptibility patterns, management practices, and mortality predictors in a tertiary teaching hospital in Lebanon. Antimicrob. Resist Infect Control. 2023 Nov;12(1):136. Soi: 10.1186/s13756-023-01343-8.
33.Intra J, Carcione D, Sala RM, Siracusa C, Brambilla P, Leoni V. Antimicrobial Resistance Patterns of Enterobacter cloacae and Klebsiella aerogenes Strains Isolated from Clinical Specimens: A Twenty-Year Surveillance Study. Vol. 12. Antibiotics. 2023. Doi: 10.3390/antibiotics12040775
34.Hilty M, Sendi P, Seiffert SN, Droz S, Perreten V, Hujer AM, Bonomo RA, Mühlemann K, Endimiani A. Characterisation and clinical features of Enterobacter cloacae bloodstream infections occurring at a tertiary care university hospital in Switzerland: is cefepime adequate therapy?. Int J. Antimicrob. Agents. 2013;41(3):236–249. Doi: 10.1016/j.ijantimicag.2012.10.022